1636-外周血肿瘤反应性T细胞表型预测肺癌免疫疗效 episode artwork

EPISODE · Oct 2, 2026 · 27 MIN

1636-外周血肿瘤反应性T细胞表型预测肺癌免疫疗效

from 聊聊Sci

这份研究探讨了通过外周血中的循环肿瘤反应性T细胞(cTR-T)来预测非小细胞肺癌患者对免疫检查点抑制剂治疗反应的方法。研究人员利用单细胞测序技术识别出了cTR-T特有的表面标志物,如CD49a、CD49b和HLA-DR,并发现这些细胞具有祖细胞样表型,能够向肿瘤内部迁移。实验表明,治疗前cTR-T中CD38的低表达以及治疗后细胞向干细胞样表型的转变,与良好的临床疗效密切相关。通过小鼠模型验证,该研究证明了cTR-T的表型动态变化可以作为评估免疫治疗效果的生物标志物。这一发现为临床监测癌症治疗进展提供了一种微创且高效的手段。References:Ito K, Iida K, Hirano T, et al. Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer[J]. Nature Communications, 2026, 17(1): 2856.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Oct 2, 2026

Embed this episode

Ready to play

1636-外周血肿瘤反应性T细胞表型预测肺癌免疫疗效

0:00 27:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 27 minutes long.

When was this 聊聊Sci episode published?

This episode was published on October 2, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!